Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative Review.

Diabetes Ther · 2021 · PMC8312211 · PMID 34309808

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Similarly, on the basis of dispensing data from the Netherlands in people with T2D, the prevalence of treatment with GLP-1 RAs was low (1.2%) between 2012 and 2017, although it did show an increasing trend over time [ 33 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.